Previous 10 | Next 10 |
Let's begin with an overview of the economic and market backdrop: The international environment is dicey. The coronavirus has injected a great deal of uncertainty into the international outlook. The bond market is still the beneficiary of a safety bid as traders seek safe haven fr...
Let's begin with an overview of the economic and market backdrop: International markets rebounded . But, the news about the negative effects of coronavirus indicates that 1Q20 and maybe 2Q20 will take a hit. The treasury market was more or less unchanged last week while other bond...
EXTON, Pa. , Feb. 17, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Robert Friel as its newest member. With the addit...
Overview In this article I present an analysis of a modified list of the Dividend Champions. I analyze all stocks in the list except the Dividend Kings. I track the Kings separately due to their long-term success in growing dividends. You can read my recent analysis update on the Dividen...
Image source: The Motley Fool. West Pharmaceutical Services (NYSE: WST) Q4 2019 Earnings Call Feb 13, 2020 , 9:00 a.m. ET Operator Continue reading
West Pharmaceutical Services, Inc. (WST) Q4 2019 Earnings Conference Call February 13, 2020 9:00 AM ET Company Participants Quintin Lai – Vice President-Investor Relations Eric Green – Chief Executive Officer Bernard Birkett – Chief Financial Officer Confe...
The following slide deck was published by West Pharmaceutical Services in conjunction with their 2019 Q4 earnings Read more ...
West Pharmaceutical (NYSE: WST ): Q4 Non-GAAP EPS of $0.82 beats by $0.10 ; GAAP EPS of $0.84 beats by $0.14 . More news on: West Pharmaceutical Services, Earnings news and commentary, Consumer stocks news, Read more ...
EXTON, Pa. , Feb. 13, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance. Fourth-Quarter and Full-Year 2019 Summary (comparisons...
EXTON, Pa. , Feb. 5, 2020 /PRNewswire/ -- (Booth #B58) West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will introduce several new, innovative pharmaceutical containment and cl...
News, Short Squeeze, Breakout and More Instantly...
West Pharmaceutical Services Inc. Company Name:
WST Stock Symbol:
NYSE Market:
West Pharmaceutical Services Inc. Website:
West Pharmaceutical Services, Inc. (NYSE: WST) reported first-quarter 2024 adjusted earnings per share (ETF:EPS) of $1.56, which beat the Zacks Con...
2024-04-25 17:21:23 ET WST has seen consistent revenue growth driven by proprietary product sales and adherence to ASC 606. Management focuses on meeting sales demand, managing competition, and strengthening the supply chain to drive growth. Key performance indicators like interest covera...
2024-04-25 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...